Expleo Solutions Receives Tax Immunity Under Vivad Se Vishwas Scheme for Assessment Year 2012-13
Expleo Solutions Limited has successfully resolved a tax dispute for Assessment Year 2012-13 through the Vivad Se Vishwas Scheme 2024, receiving immunity against disputed tax of INR 49,59,847 without any payment. The dispute originated from disallowed professional expenses due to non-deduction of TDS, but the company confirms no material impact on its financial position or operations following this settlement.

*this image is generated using AI for illustrative purposes only.
Expleo solutions Limited has announced the successful resolution of a tax dispute through the Vivad Se Vishwas Scheme 2024, receiving immunity against disputed tax obligations for Assessment Year 2012-13. The company disclosed this development to stock exchanges as part of its regulatory compliance obligations.
Tax Settlement Details
The Principal Commissioner of Income Tax 1, Chennai, issued an order dated March 20, 2026, which the company received on March 24, 2026. Under this settlement, Expleo Solutions has been granted complete immunity against disputed tax amounting to INR 49,59,847 without any payment requirement.
| Parameter | Details |
|---|---|
| Assessment Year | 2012-13 |
| Disputed Tax Amount | INR 49,59,847 |
| Settlement Amount Paid | Rs NIL |
| Authority | Principal Commissioner of Income Tax 1, Chennai |
| Order Date | March 20, 2026 |
| Receipt Date | March 24, 2026 |
Background of Tax Dispute
The original tax dispute for Assessment Year 2012-13 arose from the disallowance of certain professional expenses due to non-deduction of Tax Deducted at Source (TDS). This resulted in additional tax liability that the company had been contesting.
The resolution came through Form 4, Order for Full and Final Settlement of Tax Arrear under Section 92(2) read with Section 93 of Finance (No 2) Act, 2024, under the Vivad Se Vishwas Scheme 2024.
Financial Impact Assessment
Expleo Solutions has clarified that this tax settlement will have no material impact on the company's financial position, operations, or other business activities. The immunity granted under the scheme effectively closes this long-standing tax matter without any financial outflow.
Regulatory Compliance
The disclosure was made pursuant to Regulation 30 read with Clause 20 of Para A of Schedule III of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The company provided comprehensive details as required under SEBI circulars dated July 13, 2023, and December 31, 2024, ensuring full transparency with stakeholders regarding this regulatory development.
Historical Stock Returns for Expleo Solutions
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.98% | +2.35% | -4.36% | -26.66% | -12.14% | +31.92% |
Will Expleo Solutions face similar TDS compliance challenges in future assessment years given the original dispute stemmed from non-deduction issues?
How might the success of this Vivad Se Vishwas Scheme settlement influence other companies with pending tax disputes to participate in similar government amnesty programs?
Could this tax dispute resolution improve Expleo Solutions' credit rating or borrowing capacity by removing contingent liabilities from its books?


































